| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CAVA | Common Stock | Options Exercise | $28.8K | +15K | +1147.67% | $1.92 | 16.3K | Nov 19, 2024 | Direct | F1 |
| transaction | CAVA | Common Stock | Sale | -$2.13M | -15K | -91.99% | $142.23 | 1.31K | Nov 19, 2024 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CAVA | Stock Options (right to buy) | Options Exercise | $0 | -15K | -45.62% | $0.00 | 17.9K | Nov 19, 2024 | Common Stock | 15K | $1.92 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Includes unvested restricted stock units. |
| F2 | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.22 to $142.27, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. |
| F3 | All of the shares subject to this option are fully vested and exercisable as of the date hereof. |